Acorah Software Products - Accounts Production 19.2.450 false true 31 August 2024 1 September 2023 false true No description of principal activity 1 September 2024 31 August 2025 31 August 2025 08931504 C Sandy iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08931504 2024-08-31 08931504 2025-08-31 08931504 2024-09-01 2025-08-31 08931504 frs-core:CurrentFinancialInstruments 2025-08-31 08931504 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 08931504 frs-bus:FilletedAccounts 2024-09-01 2025-08-31 08931504 frs-bus:Micro-entities 2024-09-01 2025-08-31 08931504 frs-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 08931504 frs-bus:Director1 2024-09-01 2025-08-31 08931504 2023-08-31 08931504 2024-08-31 08931504 2023-09-01 2024-08-31 08931504 frs-core:CurrentFinancialInstruments 2024-08-31
Registered number: 08931504
Klinical Consulting Ltd.
Unaudited Financial Statements
For The Year Ended 31 August 2025
Balance Sheet
Registered number: 08931504
2025 2024
£ £
Current assets 6,874 8,468
Creditors: Amounts Falling Due Within One Year (10,001 ) (11,193 )
NET CURRENT LIABILITIES (3,127 ) (2,725 )
TOTAL ASSETS LESS CURRENT LIABILITIES (3,127 ) (2,725 )
NET LIABILITIES (3,127 ) (2,725 )
CAPITAL AND RESERVES (3,127 ) (2,725 )

Notes

1. General Information
Klinical Consulting Ltd. is a private company, limited by shares, incorporated in England & Wales, registered number 08931504 . The registered office is 84 South Croxted Road,, London, , England, , SE21 8BD.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
C Sandy
Director
29 May 2026